Pf 155, a candidate for a blood stage vaccine in Plasmodium falciparum malaria. 1985

K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann

Pf 155 is a Mr 155,000 P. falciparum antigen, which is deposited in the erythrocyte membrane at merozoite invasion. The antigen is detected by a modified immunofluorescence assay giving staining of the surface of ring stage infected erythrocytes. Cell lines producing human monoclonal antibodies to Pf 155 were established and two different antibodies of IgM and IgG class, respectively, were characterized further. Both antibodies gave a strong surface immunofluorescence and in immunoblotting they react strongly with Pf 155, but also with some lower molecular weight material, including polypeptides of Mr 135,000 and 120,000. Both antibodies were efficient inhibitors of P. falciparum reinvasion in vitro. Pf 155 as well as the Mr 135,000 and 120,000 polypeptides were shown to bind with high affinity to human erythrocyte glycophorin. An octapeptide (GluGluAsnValGluHisAspAla) corresponding to a repeated sequence in Pf 155 was synthesized. Rabbit antibodies to the octapeptide gave a distinct surface immunofluorescence and reacted with Pf 155 and the Mr 135,000 and 120,000 polypeptides in immunoblotting. Human antibodies reacting with the octapeptide were isolated by affinity chromatography from the serum of a P. falciparum immune individual. These antibodies showed a strong reaction with Pf 155 as determined by immunoblotting and surface immunofluorescence. Pf 155 reactive antibodies affinity purified on monolayers of P. falciparum infected erythrocytes are very efficient inhibitors of parasite reinvasion. Such antibody preparations depleted of octapeptide reactive antibodies showed a markedly decreased reinvasion inhibitory capacity, while a high inhibitory activity was recovered in the octapeptide reactive antibodies. Pf 155 fulfills several criteria thought to be proper for antigens involved in anti-malarial protective immunity.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006021 Glycophorins The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin. Erythrocyte Sialoglycoproteins,Glycoconnectin,Glycoconnectins,Glycophorin,Glycophorin D,MN Sialoglycoprotein,Red Blood Cell Membrane Sialoglycoprotein,Glycophorin A,Glycophorin A(M),Glycophorin B,Glycophorin C,Glycophorin E,Glycophorin HA,Ss Erythrocyte Membrane Sialoglycoproteins,Ss Sialoglycoprotein,beta-Sialoglycoprotein,Sialoglycoprotein, MN,Sialoglycoprotein, Ss,Sialoglycoproteins, Erythrocyte,beta Sialoglycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens

Related Publications

K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
January 2019, Frontiers in immunology,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
December 2023, Expert review of vaccines,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
March 2015, Trends in parasitology,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
January 2024, Biomolecules,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
January 2015, PloS one,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
August 1991, Molecular and biochemical parasitology,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
September 2002, Journal of molecular biology,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
January 2015, PloS one,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
September 1996, Infection and immunity,
K Berzins, and H Perlmann, and R Udomsangpetch, and B Wåhlin, and M Wahlgren, and M Troye-Blomberg, and J Carlsson, and A Björkman, and P Perlmann
August 2011, Vaccine,
Copied contents to your clipboard!